Report copyright - Standard of care for anal squamous cancer...ESMO PRECEPTORSHIP PROGRAM Comparison 1 versus 2 doses no difference PFS (HR 0.85, 95% CI 0.37–1.92), CFS (HR 0.91, 95% CI 0.31–2.67)
Please pass captcha verification before submit form
Please pass captcha verification before submit form